PROCEPT BioRobotics Corporation Common Stock PRCT
$17.82
-1.85%
at last close
Analyst Consensus
- Consensus Rating
- Hold (6 Buy · 6 Hold · 1 Sell)
- Average Price Target
- $28.64
- Implied Upside
- +60.7%
- Price Target Range
- $20.00 – $51.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-10-07 | BarclaysChristopher Pasquale |
Initiates coverage on | Overweight | $30 |
| 2026-08-05 | TD CowenJoshua Jennings |
Maintains | Buy | $34 → $28 |
| 2026-08-05 | Piper SandlerMatt O'Brien |
Maintains | Overweight | $35 → $25 |
| 2026-08-05 | Evercore ISI GroupVijay Kumar |
Maintains | Outperform | $30 → $23 |
| 2026-08-05 | William BlairBrandon Vazquez |
Downgrades | Outperform → Market perform | — |
| 2026-07-28 | UBSDanielle Antalffy |
Assumes | Buy → Neutral | $20 |
| 2026-07-06 | Truist SecuritiesRichard Newitter |
Downgrades | Buy → Hold | $30 → $25 |
| 2026-06-24 | Evercore ISI GroupVijay Kumar |
Initiates coverage on | Outperform | $30 |
| 2026-06-11 | Leerink PartnersMike Kratky |
Downgrades | Outperform → Market perform | $31 → $29 |
| 2026-04-30 | Piper SandlerMatt O'Brien |
Reiterates | Overweight | $28 → $35 |
| 2026-03-06 | BairdDavid Rescott |
Initiates coverage on | Neutral | $30 |
| 2026-03-02 | Truist SecuritiesRichard Newitter |
Maintains | Buy | $47 → $30 |
| 2026-02-26 | Leerink PartnersMike Kratky |
Maintains | Outperform | $55 → $30 |
| 2026-02-26 | TD CowenJoshua Jennings |
Maintains | Buy | $50 → $34 |
| 2026-02-26 | OppenheimerSuraj Kalia |
Downgrades | Outperform → Perform | — |
| 2026-02-26 | Piper SandlerMatt O'Brien |
Maintains | Overweight | $50 → $28 |
| 2026-02-26 | Wells FargoNathan Treybeck |
Maintains | Overweight | $51 → $34 |
| 2026-02-26 | B of A SecuritiesCraig Bijou |
Downgrades | Neutral → Underperform | $38 → $20 |
| 2025-12-18 | Truist SecuritiesRichard Newitter |
Maintains | Buy | $50 → $47 |
| 2025-12-12 | UBSDanielle Antalffy |
Initiates coverage on | Buy | $62 |
| 2025-12-08 | B of A SecuritiesCraig Bijou |
Downgrades | Buy → Neutral | $55 → $38 |
| 2025-12-02 | Morgan StanleyPatrick Wood |
Maintains | Overweight | $56 → $51 |
| 2025-11-05 | TD CowenJoshua Jennings |
Maintains | Buy | $85 → $50 |
| 2025-11-05 | Piper SandlerMatt O'Brien |
Reiterates | Overweight | $55 → $50 |
| 2025-11-05 | Wells FargoNathan Treybeck |
Maintains | Overweight | $58 → $51 |
| 2025-10-15 | Truist SecuritiesRichard Newitter |
Maintains | Buy | $64 → $50 |
| 2025-09-16 | BTIGRyan Zimmerman |
Reiterates | Neutral | — |
| 2025-09-02 | OppenheimerSuraj Kalia |
Upgrades | Perform → Outperform | $60 |
| 2025-08-07 | Wells FargoNathan Treybeck |
Maintains | Overweight | $75 → $58 |
| 2025-08-07 | Piper SandlerMatt O'Brien |
Maintains | Overweight | $80 → $55 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $17.82
- Market Cap
- $1.04 billion
- 52-Week Range
- $16.66 – $40.10
- Average Volume
- 1.39 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.